FIE Fielmann Group AG

46.39USD42.30 EUR · XETRA-0.59%Mkt Cap: 3.90B USDP/E: 16.08

Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames a…

Institutional holders11 on file

Key Statistics

Company
Market Cap3.90B USD
Enterprise Value4.58B USD
Revenue (TTM)2.73B USD
Gross Profit2.14B USD
Net Income (TTM)223.45M USD
Revenue/Share32.58 USD
Last Price46.39 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees18.2K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0005772206
Valuation
P/E (Trailing)16.08
P/E (Forward)15.47
PEG3.20
EV/EBITDA9.31
EV/Revenue1.68
P/S1.43
P/B3.21
EPS (TTM)2.88 USD
EPS (Forward)3.00 USD
52W Range
40.2050% of range52.59
52W High52.59 USD
52W Low40.20 USD
Profitability
Gross Margin79.94%
Oper. Margin13.70%
EBITDA Margin18.00%
Profit Margin8.37%
ROE20.75%
ROA8.20%
ROIC17.90%
ROCE21.77%
Growth
Revenue Growth4.70%
Earnings Growth11.30%
Cash Flow & Leverage
Operating CF544.00M USD
CapEx (TTM)127.00M USD
FCF Margin—
FCF Yield—
Net Debt685.67M USD
Net Debt/EBITDA1.40
Net Debt/FCF—
Balance Sheet
Debt/Equity0.90
Current Ratio—
Quick Ratio—
Book Value/Sh14.44 USD
Cash/Share3.53 USD
Dividends
Fwd Div Rate1.54 USD
Trail. Div Rate0.00 USD
Div. Yield3.25%
5Y Avg Yield2.40%
Payout Ratio55.12%
Ex-Div DateJul 10, 2026
Pay Date—
Splits
Last Split2:1
Split DateAug 22, 2014
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)60.19 USD
Upside (mean)+29.7%
Target Range47.16 USD – 70.20 USD
47.16+29.7% to mean70.20
# Analysts8
Ownership
Shares Out.83.96M
Float22.61M
Insiders72.91%
Institutions9.69%
Technical
SMA 5043.16 (+7.5%)
SMA 20045.94 (+1.0%)
Beta0.60
S&P 52W Chg12.00%
Avg Vol (30d)54.03K
Avg Vol (10d)68.15K
Technical Indicators
RSI (14)57.9
MACD1.1122
MACD Signal1.1642
MACD Hist.-0.0520
BB Upper49.59 USD
BB Middle45.79 USD
BB Lower41.98 USD
BB Width16.62%
ATR (14)0.9435 USD
Vol Ratio (20d)0.57x

About Fielmann Group (ETR: FIE)

›

Fielmann Group (ETR: FIE) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 18,213 employees.

The shares were at 42.30 EUR on 19 November 2026, down 2.4% over 52 weeks. Its 52-week range is 36.65 EUR to 47.95 EUR: the price is 11.8% below the high and 15.4% above the low.

At a market capitalisation of 3.55B EUR, it trades at 16.1 times trailing earnings and 15.5 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 67% for FIE. It pays a dividend yielding 3.25% (it pays out 55% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Fielmann Group reports return on equity of 20.8%, an operating margin of 13.7% and revenue up 4.7% year over year.

Its debt exceeds its cash by 625.16M EUR, a debt-to-equity ratio of 0.90. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 54.88 EUR is 29.7% above the current price. The next earnings report is expected on 3 March 2027.